Drug development is inherently complex, with numerous interdependent activities and critical decisions at every stage. The difference between a program that stalls and one that reaches its milestones often comes down to a single factor: how tightly science and strategy are integrated from the very beginning. To navigate that complexity, Evotec applies a governance model built for large, multifaceted programs, one that relies on senior experts who can transform scientific complexity into clear strategy and reliable delivery. At the center of that model sits the Scientific Project Leader (SPL).
Why Development Programs Need Strategic Science
Strategic science plays a pivotal role in establishing the right development plan from the beginning and adapting it dynamically as project-generated data become available. A development pathway is not a fixed sequence of tasks; it is a living strategy that must respond to new information while keeping timelines short and asset value high. Success depends on a seamless integration of science and strategy, and that integration rarely happens on its own. Evotec established the Scientific Project Leadership function specifically to lead strategic science within cross-functional, integrated development programs, so that scientific decisions and program strategy move together rather than in parallel.
A Role Modeled After Big Pharma
Many CROs, CDMOs, and CMOs rely on governance structures built around function-by-function planning, and they lack an equivalent role to coordinate across those functions. Evotec's Scientific Project Leader is modeled after big pharma organizations, where Project and Program Leaders hold a genuinely strategic mandate: orchestrating cross-functional work and carrying accountability for progression through development stages. An SPL understands the requirements of the overall drug development lifecycle and can work hand in hand with big pharma to define the right scope for a project.
Equally, an SPL acts as a development expert for biotechs, academia, and consortia, serving as a scientific strategist who ensures that a sound, value-maximizing development plan is established for their key assets. Whatever the program or customer, an SPL brings unified scientific leadership, strategic coherence, and cross-functional alignment that measurably improve quality, speed, and decision-making across the development lifecycle.
One Scientific Partner Across the Development Lifecycle
At Evotec, the SPL brings all scientific disciplines together under a single, integrated development strategy, reducing fragmentation and minimizing inconsistencies. This holistic oversight spans CMC, preclinical, regulatory, and clinical functions, ensuring that knowledge flows seamlessly between disciplines rather than being lost at the interfaces where handovers so often introduce delay and risk.
Acting as the client's primary scientific partner, the SPL is a single, always-available point of contact for the status of a project. Embedded in operations, the SPL coordinates multidisciplinary teams to deliver a clear, tailored roadmap, keeping the big picture in view and the details under control. They act as your scientist on the ground, connecting disciplines, anticipating risks and opportunities through proactive scenario planning, and adapting strategies to maintain momentum and scientific integrity at every step.
What Sets Evotec Apart with SPLs
Five capabilities distinguish the Evotec SPL model:
- Strategic leadership. The SPL creates a tailored, client-centric development strategy aligned with available compound information, regulatory expectations, and client objectives.
- Agile delivery. SPLs actively map potential risks and identify opportunities to adjust the project course while optimizing timeline, efficiency, and quality.
- Scientific depth. With a holistic view across CMC, preclinical, and regulatory domains, SPLs bring the cross-functional team together to deliver robust, science-driven strategy and execution.
- Integrated approach. Coordinated execution across disciplines enables faster, data-informed decisions, with 360-degree problem solving and no knowledge gaps between areas.
- Client partnership. SPLs act as trusted scientific advisors and the first-line point of contact for any request or technical question, aligning every step with client goals and patient needs.
Anticipating Risk, Sustaining Momentum
The value of an SPL is most visible when a program meets the unexpected. Because the SPL holds the whole picture, they can anticipate where a program is likely to encounter friction, whether in CMC, ADME, or another area, and plan for it before it becomes a delay. Proactive scenario planning means alternative pathways are considered in advance, so decisions can be made quickly and with scientific integrity intact when data shift the plan. The result is a program that keeps moving through complexity rather than pausing at every interface.
Meet Your Scientific Project Leaders
Nicola Fasdelli, Senior Scientific Project Leader
"I am passionate about transforming innovative ideas into real-world treatments. For me, success in drug development is not just about meeting milestones, it is about foresight, collaboration, and adaptability. I really enjoy working with a multidisciplinary team of scientists in an integrated environment, and interacting with the client to support the strategy and the project's success."
Adriana De Simone, Scientific Project Leader - Integrated Development Program
"I am passionate about leading integrated projects and shaping scientific strategy from concept through execution. By combining a strong scientific foundation with program leadership expertise, I help identify potential challenges early and translate complexity into clear, actionable plans across CMC, preclinical development, and discovery programs. What I find most rewarding is collaborating closely with clients and multidisciplinary teams, ensuring scientific objectives are aligned with broader business and development goals while navigating critical decisions together. Ultimately, I am driven by the power of collaboration and the opportunity to accelerate the development of innovative therapies that can make a meaningful difference for patients."
A New Standard for Integrated Development
The convergence of deep scientific expertise and program leadership represents a shift in how integrated development is run. With an SPL deployed, every type of program and customer benefits from a single accountable scientific partner who keeps science and strategy aligned from the first plan to the final milestone. For biotechs and pharma alike, that translates into shorter timelines, better decisions, and a development journey that is followed closely, accurately, and with the asset's value always in view.
Learn More
Evotec's Scientific Project Leaders sit at the heart of its integrated development offering, guiding assets through CMC, preclinical, regulatory, and clinical stages as a single, strategic scientific partner.
For more information about how Evotec's Scientific Project Leadership function can support your development program talk to a scientific project leader.